Skip to main content

Description:  In this 2-day workshop, Amy Wagner and Kelly Koerner will teach the concepts and practical skills needed to conceptualize the problems of clients who have reduced high-risk intentional self-injury and other out-of-control behaviors, yet continue to struggle with significant emotion regulation difficulties and trauma-related problems. Many researchers and clinicians have offered ideas on Stage II DBT. In the first morning lecture, open to the wider community, the presenters will summarize the state of the current thinking and options available for treatment. A framework for case formulation and treatment planning will be presented.


Kelly Koerner, Ph.D.

Kelly Koerner, Ph.D., is a clinical psychologist and an expert clinician, clinical supervisor and trainer in Dialectical Behavior Therapy, and Creative Director and CEO of the Evidence-Based Practice Institute, where she explores how technology can scale learning and collaboration so practitioners get better clinical outcomes. She received her Ph.D. from the University of Washington and has specialized training in a number of evidence based treatments. She has served as: Director of Training for Marsha Linehan’s research investigating the efficacy of DBT for suicidal and drug abusing individuals with borderline personality disorder; Creative Director at Behavioral Tech Research where she developed e-learning and other technology based methods to disseminate evidence-based practices; and co-founder and first CEO of Behavioral Tech, a company that provides training in DBT. Her most recent publications include Doing Dialectical Behavior Therapy: A Practical Guide (Guides to Individualized Evidence-Based Treatment) and Dialectical Behavior Therapy in Clinical Practice: Applications across Disorders and Settings.

Amy W. Wagner, Ph.D.

Amy Wagner, Ph.D., is an associate professor of psychology in the Department of Psychiatry at Oregon Health & Science University, staff psychologist for the PTSD Clinical Team at Portland Veteran Affairs Medical Center, and member of its clinical psychology training program.  She received her Ph.D. from the University of Washington, and postdoctoral training at the National Center for PTSD, Women’s Division, at the Boston VA Medical Center. Since that time she has held faculty positions at the University of Wyoming and the Department of Psychiatry & Behavioral Sciences at the University of Washington. Dr. Wagner joined the Vancouver division of PVAMC in September 2005. She has clinical expertise in cognitive-behavioral therapy for PTSD and anxiety disorders more generally, as well as Dialectical Behavior Therapy. She has research interests in treatment development and evaluation, emotion regulation, and treatment dissemination. Through a VA Merit grant she is currently examining the effectiveness and acceptability of Behavioral Activation Therapy for the early treatment of PTSD and depression among Veterans who served in Iraq and Afghanistan.

Resources: For resources on these topics, see articles or book chapter coauthored by Amy Wagner, and useful DBT guides by Kelly Koerner, listed under her bio below.


Learning objectives:  By the end of this workshop, participants will be able to:

  1. Describe how DBT’s biosocial theory accounts for the role of trauma in the initiation and maintenance of client problems
  2. Describe the developmental sequelae that can result from pervasive emotion dysregulation
  3. List common targets treated in Stage 2 DBT
  4. Conceptualize the top three Stage 2 targets for one of their own clients
  5. Conceptualize common targets as attempts (or failed attempt to regulate emotion)
  6. Describe the steps of the treatment plans to address common stage 2 targets.


  1. Introduction to Stage 2 in DBT
  2. Application of case formulation
  3. Treating Common Targets: Dissociation
  4. Treating Common Targets: Self-hatred, Self-invalidation, & Shame
  5. Treating Common Targets:  Ongoing Exquisite Sensitivity & Emotion Dysregulation
  6. Treating Common Targets:  PTSD Symptoms
  7. Treating Common Targets:  Inhibited Grieving and Experiential Avoidance
  8. Treating Common Targets:  Problems in Intimate Relationships including Therapy
  9. Treating Common Targets:  Difficulty Envisioning a Life Worth Living


Clinical Institute at the University of North Carolina at Chapel Hill School of Social Work

Comments are closed.